Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Massive study aims to unlock secrets of early blood cancers

NCT ID NCT02269592

First seen Dec 08, 2025 · Last updated Jun 16, 2026 · Updated 23 times

Summary

This study looks at genetic changes in people with early-stage blood cancers or conditions that may lead to cancer. Researchers will analyze blood, bone marrow, or cheek cell samples from up to 10,000 participants to find DNA errors linked to cancer risk and progression. The goal is to better understand why these cancers develop and how to improve treatment and prevention.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMOLDERING MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana Farber Cancer Institute at Merrimack Valley

    RECRUITING

    Methuen, Massachusetts, 01844, United States

    Contact

    Contact

  • Dana Farber Cancer Institute at Milford Regional Medical Center

    RECRUITING

    Milford, Massachusetts, 01757, United States

    Contact

    Contact

  • Dana Farber Cancer Institute at South Shore

    RECRUITING

    Weymouth, Massachusetts, 02190, United States

    Contact

    Contact

  • Dana Farber Cancer Institute at St. Elizabeth's

    RECRUITING

    Brighton, Massachusetts, 02135, United States

    Contact

    Contact

  • Dana Farber/New Hampshire Oncology-Hematology

    RECRUITING

    Londonderry, New Hampshire, 03053, United States

    Contact

    Contact

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • West Michigan Cancer Center

    RECRUITING

    Kalamazoo, Michigan, 49007, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia B-cell chronic lymphocytic leukemia hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm leukemia, chronic lymphocytic, susceptibility to, 2 monoclonal gammopathy of uncertain significance myelodysplastic syndrome Myelodysplastic Syndromes premalignant hematological system disease Smoldering Multiple Myeloma smoldering plasma cell myeloma Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.